Appetite suppression is maximal
About 7% of people ages 18 to 29 have taken a GLP-1, followed by 6% of people ages 30 to 49
Three months on a GLP-1 microdosing program, she dropped 13 pounds, shifted her diet toward protein, and cut out sugar cravings shed battled for years
A 2024 double-blind randomized trial of 156 participants with early Parkinsons disease found that participants receiving a GLP-1 drug, lixisenatide, showed no progression of motor symptoms, compared to a measurable worsening on standard motor scales in the placebo group
While tirzepatide works by activating the GLP-1 and GIP receptors, retatrutide activates GLP-1, GIP, and GCG receptors, which may offer even more benefits
Todos los pacientes deben consultar a un mdico para que les oriente sobre su uso adecuado